Q96IZ0 (PAWR_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
January 25, 2012.
Version 83.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: PRKC apoptosis WT1 regulator protein Alternative name(s): Prostate apoptosis response 4 protein Short name=Par-4 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Protein attributes
| Sequence length | 340 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Pro-apoptopic protein capable of selectively inducing apoptosis in cancer cells, sensitizing the cells to diverse apoptotic stimuli and causing regression of tumors in animal models. Induces apoptosis in certain cancer cells by activation of the Fas prodeath pathway and coparallel inhibition of NF-kappa-B transcriptional activity. Inhibits the transcriptional activation and augments the transcriptional repression mediated by WT1. Down-regulates the anti-apoptotic protein BCL2 via its interaction with WT1. Seems also to be a transcriptional repressor by itself. May be directly involved in regulating the amyloid precursor protein (APP) cleavage activity of BACE1. Ref.6 |
| Subunit structure | Interacts with WT1, via the C-terminal region. Homooligomer. Interacts also with a wide variety of proteins, such as atypical PKCs, p62, DAPK3 kinase and THAP1. Interacts with actin, AATF, BACE1, SPSB1, SPSB2 AND SPSB4. Component of a ternary complex composed of SQSTM1 and PRKCZ. Ref.1 Ref.7 Ref.8 Ref.9 Ref.10 |
| Subcellular location | Cytoplasm. Nucleus. Note: Mainly cytoplasmic in absence of apoptosis signal and in normal cells. Nuclear in most cancer cell lines. Nuclear entry seems to be essential but not sufficient for apoptosis By similarity. Nuclear localization includes nucleoplasm and PML nuclear bodies. Ref.1 Ref.8 |
| Tissue specificity | Widely expressed. Expression is elevated in various neurodegenerative diseases such as amyotrophic lateral sclerosis, Alzheimer, Parkinson and Huntington diseases and stroke. Down-regulated in several cancers. Ref.1 |
| Induction | By apoptosis. |
| Domain | The leucine-zipper domain is not essential for apoptosis, but is required for sensitization of cells to exogenous apoptotic insults and for interaction with its partners By similarity. The SAC domain is a death-inducing domain selective for apoptosis induction in cancer cells. This domain is essential for nuclear entry, Fas activation, inhibition of NF-kappa-B activity and induction of apoptosis in cancer cells By similarity. |
| Post-translational modification | Preferentially phosphorylated at the Thr-163 by PKC in cancer cells By similarity. Ref.13 Ref.14 |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| HSPA5 | P11021 | 8 | EBI-595869,EBI-354921 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 340 | 340 | PRKC apoptosis WT1 regulator protein | PRO_0000058236 | |||||
Regions | |||||||||
| Domain | 300 – 340 | 41 | Leucine-zipper | ||||||
| Region | 145 – 203 | 59 | Selective for apoptosis induction in cancer cells (SAC) | ||||||
| Coiled coil | 186 – 206 | 21 | Potential | ||||||
| Motif | 145 – 161 | 17 | Nuclear localization signal By similarity | ||||||
| Compositional bias | 49 – 120 | 72 | Ala-rich | ||||||
Amino acid modifications | |||||||||
| Modified residue | 163 | 1 | Phosphothreonine; by PKA By similarity | ||||||
| Modified residue | 226 | 1 | Phosphotyrosine Ref.13 | ||||||
| Modified residue | 228 | 1 | Phosphoserine Ref.13 | ||||||
| Modified residue | 229 | 1 | Phosphothreonine Ref.13 | ||||||
| Modified residue | 231 | 1 | Phosphoserine Ref.13 Ref.14 | ||||||
| Modified residue | 233 | 1 | Phosphoserine Ref.14 | ||||||
Natural variations | |||||||||
| Natural variant | 42 | 1 | P → L. Ref.3 | VAR_022465 | |||||
| Natural variant | 78 | 1 | P → R. Ref.2 Ref.3 Corresponds to variant rs8176805 [ dbSNP | Ensembl ]. | VAR_022466 | |||||
| Natural variant | 137 | 1 | G → A. Ref.3 | VAR_022467 | |||||
| Natural variant | 202 | 1 | E → A. Ref.3 Corresponds to variant rs8176870 [ dbSNP | Ensembl ]. | VAR_022468 | |||||
Experimental info | |||||||||
| Sequence conflict | 102 – 103 | 2 | AP → PPAR in AAC24947. Ref.1 | ||||||
| Sequence conflict | 199 | 1 | I → M in CAG38786. Ref.2 | ||||||
| Sequence conflict | 281 | 1 | R → T in AAC24947. Ref.1 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "A novel repressor, par-4, modulates transcription and growth suppression functions of the Wilms' tumor suppressor WT1." Johnstone R.W., See R.H., Sells S.F., Wang J., Muthukkumar S., Englert C., Haber D.A., Licht J.D., Sugrue S.P., Roberts T., Rangnekar V.M., Shi Y. Mol. Cell. Biol. 16:6945-6956(1996) [PubMed: 8943350] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, TISSUE SPECIFICITY, INTERACTION WITH WT1. |
| [2] | "Cloning of human full open reading frames in Gateway(TM) system entry vector (pDONR201)." Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B. Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANT ARG-78. |
| [3] | NIEHS SNPs program Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS LEU-42; ARG-78; ALA-137 AND ALA-202. |
| [4] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Kidney. |
| [5] | "Structural and functional characterization of the upstream regulatory region of the human gene encoding prostate apoptosis response factor-4." Hsu S.-C., Kirschenbaum F., Miller J., Cordell B., McCarthy J.V. Gene 295:109-116(2002) [PubMed: 12242017] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-64. Tissue: Blood. |
| [6] | "Par-4 drives trafficking and activation of Fas and Fasl to induce prostate cancer cell apoptosis and tumor regression." Chakraborty M., Qiu S.G., Vasudevan K.M., Rangnekar V.M. Cancer Res. 61:7255-7263(2001) [PubMed: 11585763] [Abstract] Cited for: FUNCTION IN APOPTOSIS AND TUMOR REGRESSION. |
| [7] | "p62 forms a ternary complex with PKCzeta and PAR-4 and antagonizes PAR-4-induced PKCzeta inhibition." Chang S., Kim J.H., Shin J. FEBS Lett. 510:57-61(2002) [PubMed: 11755531] [Abstract] Cited for: INTERACTION WITH SQSTM1 AND PRKCZ. |
| [8] | "THAP1 is a nuclear proapoptotic factor that links prostate-apoptosis-response-4 (Par-4) to PML nuclear bodies." Roussigne M., Cayrol C., Clouaire T., Amalric F., Girard J.-P. Oncogene 22:2432-2442(2003) [PubMed: 12717420] [Abstract] Cited for: SUBCELLULAR LOCATION, INTERACTION WITH THAP1. |
| [9] | "AATF inhibits aberrant production of amyloid beta peptide 1-42 by interacting directly with Par-4." Guo Q., Xie J. J. Biol. Chem. 279:4596-4603(2004) [PubMed: 14627703] [Abstract] Cited for: INTERACTION WITH AATF. |
| [10] | "PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein." Xie J., Guo Q. J. Biol. Chem. 280:13824-13832(2005) [PubMed: 15671026] [Abstract] Cited for: INTERACTION WITH BACE1. |
| [11] | "Apoptosis by Par-4 in cancer and neurodegenerative diseases." El-Guendy N., Rangnekar V.M. Exp. Cell Res. 283:51-66(2003) [PubMed: 12565819] [Abstract] Cited for: REVIEW ON FUNCTION IN APOPTOSIS AND NEURODEGENERATIVE DISEASES. |
| [12] | "Par-4 inducible apoptosis in prostate cancer cells." Gurumurthy S., Rangnekar V.M. J. Cell. Biochem. 91:504-512(2004) [PubMed: 14755681] [Abstract] Cited for: REVIEW. |
| [13] | "Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry." Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A. Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007) [PubMed: 17287340] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-226; SER-228; THR-229 AND SER-231, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [14] | "Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-231 AND SER-233, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [15] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | U63809 mRNA. Translation: AAC24947.1. CR536549 mRNA. Translation: CAG38786.1. AY300794 Genomic DNA. Translation: AAP43693.1. BC007018 mRNA. Translation: AAH07018.1. AF503628 Genomic DNA. Translation: AAM27453.1. | ||||||||||||
| IPI | IPI00001871. | ||||||||||||
| RefSeq | NP_002574.2. NM_002583.2. | ||||||||||||
| UniGene | Hs.643130. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q96IZ0. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-29003N. | ||||||||||||
| IntAct | Q96IZ0. 7 interactions. | ||||||||||||
| MINT | MINT-1418971. | ||||||||||||
| STRING | Q96IZ0. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q96IZ0. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 66773935. | ||||||||||||
Proteomic databases | |||||||||||||
| PeptideAtlas | Q96IZ0. | ||||||||||||
| PRIDE | Q96IZ0. | ||||||||||||
Protocols and materials databases | |||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000328827; ENSP00000328088; ENSG00000177425. | ||||||||||||
| GeneID | 5074. | ||||||||||||
| KEGG | hsa:5074. | ||||||||||||
| UCSC | uc001syx.1. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 5074. | ||||||||||||
| GeneCards | GC12M079960. | ||||||||||||
| H-InvDB | HIX0022199. | ||||||||||||
| HGNC | HGNC:8614. PAWR. | ||||||||||||
| HPA | CAB020779. HPA012640. | ||||||||||||
| MIM | 601936. gene. | ||||||||||||
| neXtProt | NX_Q96IZ0. | ||||||||||||
| PharmGKB | PA32954. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | prNOG19772. | ||||||||||||
| GeneTree | ENSGT00390000000406. | ||||||||||||
| HOGENOM | HBG278683. | ||||||||||||
| HOVERGEN | HBG058812. | ||||||||||||
| InParanoid | Q96IZ0. | ||||||||||||
| OMA | FPRYNRD. | ||||||||||||
| OrthoDB | EOG4001K8. | ||||||||||||
| PhylomeDB | Q96IZ0. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| Pathway_Interaction_DB | ceramidepathway. Ceramide signaling pathway. ar_pathway. Coregulation of Androgen receptor activity. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q96IZ0. | ||||||||||||
| Bgee | Q96IZ0. | ||||||||||||
| CleanEx | HS_PAWR. | ||||||||||||
| Genevestigator | Q96IZ0. | ||||||||||||
| GermOnline | ENSG00000177425. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| NextBio | 19552. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | PAWR_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q96IZ0 Secondary accession number(s): O75796, Q6FHY9, Q8N700 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 12 Human chromosome 12: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |

Clusters with